Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2612456 | 0.85 | GAA (0.67) | GAAALDH1A1CYP19A1HPGDHSD17B10 | |
| SCHEMBL4689639 | 0.85 | GAA (0.67) | GAAALDH1A1CYP19A1HPGDHSD17B10 | |
| SCHEMBL26459783 | 0.84 | CYP3A4 (0.44) | GAAALDH1A1HPGDMAPTSMN1; SMN2 | |
| SCHEMBL2612468 | 0.84 | GAA (0.65) | GAAALDH1A1CYP19A1HPGDHSD17B10 | |
| SCHEMBL17172384 | 0.83 | GAA (0.41) | GAAALDH1A1HPGDSHBGMAPT | |
| SCHEMBL2612462 | 0.83 | GAA (0.63) | GAAALDH1A1CYP19A1HPGDHSD17B10 | |
| SCHEMBL13256708 | 0.83 | GAA (0.63) | GAAALDH1A1CYP19A1HPGDHSD17B10 | |
| SCHEMBL824482 | 0.83 | GAA (0.63) | GAAALDH1A1CYP19A1HPGDHSD17B10 | |
| SCHEMBL14556835 | 0.82 | CYP3A4 (0.41) | GAAALDH1A1HPGDSHBGHSD17B10 | |
| SCHEMBL22068545 | 0.80 | MAPT (0.40) | GAAALDH1A1HPGDSHBGMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8246880-B2 | Method of producing cellulose ester film, cellulose ester film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2012-08-21 | — | — | US | disclosed |
| US-8246880-B2 | Method of producing cellulose ester film, cellulose ester film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2012-08-21 | — | — | US | disclosed |
| US-20100151156-A1 | METHOD OF PRODUCING CELLULOSE ESTER FILM, CELLULOSE ESTER FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | KONICA MINOLTA OPTO, INC. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100151156-A1 | METHOD OF PRODUCING CELLULOSE ESTER FILM, CELLULOSE ESTER FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | KONICA MINOLTA OPTO, INC. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-7176252-B2 | Solid melt blended phosphite composites | DOVER CHEMICAL CORPORATION (US) | 2007-02-13 | — | — | US | disclosed |
| US-20040164279-A1 | Solid melt blended phosphite composites | WELLS FARGO BANK, NATIONAL ASSOCIATION | 2004-08-26 | — | — | US | disclosed |
| EP-0545861-B1 | Diphenylacetic acid derivatives as stabilisers for organic material | CIBA GEIGY AG (CH) | 1995-12-27 | — | — | EP | disclosed |
| US-5260430-A | Stabilizers for organic materials against oxidative, thermal and light degradation | CIBA-GEIGY CORPORATION (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0545861-A2 | Diphenylacetic acid derivatives as stabilisers for organic material | CIBA-GEIGY AG (CH) | 1993-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040164279-A1 | Solid melt blended phosphite composites | PHOSPHO1, MTAP, INPPL1 | GAA 2474/4885ALDH1A1 2924/4885CYP19A1 3321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.